HK80493A - Nasal pharmaceutical composition containing a somatostatin anologue - Google Patents

Nasal pharmaceutical composition containing a somatostatin anologue Download PDF

Info

Publication number
HK80493A
HK80493A HK804/93A HK80493A HK80493A HK 80493 A HK80493 A HK 80493A HK 804/93 A HK804/93 A HK 804/93A HK 80493 A HK80493 A HK 80493A HK 80493 A HK80493 A HK 80493A
Authority
HK
Hong Kong
Prior art keywords
compsn
nasal
anologue
somatostatin
pharmaceutical composition
Prior art date
Application number
HK804/93A
Other languages
English (en)
Inventor
Azria Moise
Cavanak Thomas
Rummelt Andreas
Doepfner Wolfgang
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620035A external-priority patent/GB8620035D0/en
Priority claimed from GB868626821A external-priority patent/GB8626821D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of HK80493A publication Critical patent/HK80493A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HK804/93A 1986-08-18 1993-08-05 Nasal pharmaceutical composition containing a somatostatin anologue HK80493A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868620035A GB8620035D0 (en) 1986-08-18 1986-08-18 Organic compounds
GB868626821A GB8626821D0 (en) 1986-11-10 1986-11-10 Organic compounds

Publications (1)

Publication Number Publication Date
HK80493A true HK80493A (en) 1993-08-13

Family

ID=26291187

Family Applications (1)

Application Number Title Priority Date Filing Date
HK804/93A HK80493A (en) 1986-08-18 1993-08-05 Nasal pharmaceutical composition containing a somatostatin anologue

Country Status (24)

Country Link
KR (1) KR880002537A (cs)
AT (1) AT396331B (cs)
AU (2) AU612589B2 (cs)
BE (1) BE1001748A4 (cs)
CA (1) CA1322331C (cs)
CH (1) CH672252A5 (cs)
CS (1) CS411491A3 (cs)
DE (1) DE3726517A1 (cs)
DK (1) DK428287A (cs)
ES (1) ES2004807A6 (cs)
FI (1) FI93307C (cs)
FR (1) FR2602680B1 (cs)
GR (1) GR871289B (cs)
HK (1) HK80493A (cs)
HU (1) HU200940B (cs)
IE (1) IE60761B1 (cs)
IL (1) IL83572A (cs)
IT (1) IT1222510B (cs)
LU (1) LU86971A1 (cs)
NL (1) NL8701874A (cs)
NO (1) NO175519C (cs)
NZ (1) NZ221473A (cs)
PT (1) PT85545B (cs)
SE (1) SE8703183L (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003216084A1 (en) 2002-01-22 2003-09-02 New York University Methods for therapeutic treatment of benign prostatic hypertrophy (bph)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4505897A (en) * 1983-04-18 1985-03-19 The Administrators Of The Tulane Educational Fund Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体

Also Published As

Publication number Publication date
DK428287D0 (da) 1987-08-17
CA1322331C (en) 1993-09-21
ES2004807A6 (es) 1989-02-01
FR2602680A1 (fr) 1988-02-19
CS411491A3 (en) 1992-06-17
PT85545B (pt) 1990-05-31
FI873548A0 (fi) 1987-08-17
GR871289B (en) 1987-12-18
SE8703183L (sv) 1988-02-19
HUT46235A (en) 1988-10-28
FI93307B (fi) 1994-12-15
IT8721670A0 (it) 1987-08-18
HU200940B (en) 1990-09-28
FI93307C (fi) 1995-03-27
NZ221473A (en) 1990-08-28
NO873452L (no) 1988-02-19
DE3726517A1 (de) 1988-03-03
IE60761B1 (en) 1994-08-10
LU86971A1 (fr) 1988-03-02
AT396331B (de) 1993-08-25
FR2602680B1 (fr) 1993-04-16
SE8703183D0 (sv) 1987-08-17
AU7712087A (en) 1988-02-25
NL8701874A (nl) 1988-03-16
AU637530B2 (en) 1993-05-27
KR880002537A (ko) 1988-05-09
AU612589B2 (en) 1991-07-18
PT85545A (en) 1987-09-01
IL83572A (en) 1992-09-06
IT1222510B (it) 1990-09-05
BE1001748A4 (fr) 1990-02-27
FI873548L (fi) 1988-02-19
IE872187L (en) 1988-02-18
NO175519B (no) 1994-07-18
NO873452D0 (no) 1987-08-17
NO175519C (no) 1994-10-26
ATA206087A (de) 1992-12-15
CH672252A5 (cs) 1989-11-15
AU8568991A (en) 1991-12-05
DK428287A (da) 1988-02-19
IL83572A0 (en) 1988-01-31

Similar Documents

Publication Publication Date Title
ZA912793B (en) Pharmaceutical formulations
BG100933A (en) Polymer coated tablets comprising amoxycilin and clavulanate
ATE189771T1 (de) Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält
ATE225647T1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
PT84416A (en) Process for the preparation of dosage forms having a regular and sustained release for oral administration containing polysaccharides of natural origin
CA2131393A1 (en) Method and apparatus for drug delivery using supercritical solutions
HUP9802828A2 (hu) Belélegezhető vivőanyag szabályozott hatóanyag-leadású gyógyszerkészítményekhez
CA2095354A1 (en) Method and composition for controlled delivery of biologically active agents
CA2098738A1 (en) Controlled Release Oxycodone Compositions
ZA912380B (en) Osmotic dosage system for liquid drug delivery
AU7461796A (en) Insoluble drug delivery
DE69519300D1 (de) Stabiles arzneimittel enthaltend oxaliplatin
DE69013473D1 (de) Cimetidin enthaltende Arzneimittel.
GB1517480A (en) Opiate analgesic formulation with a low potential for abuse
WO1997045091A3 (en) Sustained release oxycodone formulations with no fed/fast effect
CA2134196A1 (en) Pharmaceutical preparation and process for its manufacture
EP0377517A3 (en) Theophylline dosage form
AU3683484A (en) The use of menthol to enhance transdermal drug delivery
IE852697L (en) Dipeptides for treatment of sclerosis
CA2256751A1 (fr) Comprime enrobe a base de maleate de trimebutine
HK80493A (en) Nasal pharmaceutical composition containing a somatostatin anologue
MY102411A (en) Nasal solutions
ID21038A (id) Tablet yang mengandung resin penukar anion
GR3029386T3 (en) Process and device for producing a flat dry-administration form with a preparation containing active medical agents
IS5107A (is) Ný efnablanda til innöndunar sem er með lausþéttniflæði frá 0,28 til 0,38 g/ml, sem inniheldur terbútalínsúlfat, aðferð við að framleiða efnablöndunaog notkun hennar

Legal Events

Date Code Title Description
NR Patent deemed never to have been added to the register under section 13(7) of patents (transitional arrangements) rules